Study of Recombinant Protein Vaccine Formulations against COVID-19 in Healthy Adults 18 Years of Age and Older

Trial Identifier: VAT00001
Sponsor: Sanofi Pasteur, a Sanofi Company
Collaborator:
GlaxoSmithKline
Start Date: September 2020
Primary Completion Date: November 2021
Study Completion Date: November 2021
Condition: Healthy Volunteers; COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Ohio Cleveland, Ohio, United States, 44122
UNITED STATES, Alabama Birmingham, Alabama, UNITED STATES, 35294
UNITED STATES, California Rolling Hills Estates, California, UNITED STATES, 90274
UNITED STATES, Florida Hollywood, Florida, UNITED STATES, 33024
UNITED STATES, Florida Melbourne, Florida, UNITED STATES, 32934
UNITED STATES, Massachusetts Boston, Massachusetts, UNITED STATES, 02115
UNITED STATES, Nebraska Omaha, Nebraska, UNITED STATES, 68134
UNITED STATES, New York Rochester, New York, UNITED STATES, 14642
UNITED STATES, New York Rochester, New York, UNITED STATES, 14609
UNITED STATES, Pennsylvania Philadelphia, Pennsylvania, UNITED STATES, 19104
UNITED STATES, South Carolina Mount Pleasant, South Carolina, UNITED STATES, 29464